Rapado González, ÓscarMartínez-Reglero, CristinaSalgado-Barreira, ÁngelTakkouche, BahiLópez López, RafaelSuárez Cunqueiro, María MercedesMuinelo-Romay, Laura2025-11-132025-11-132020-04-11Rapado-González, Ó., Martínez-Reglero, C., Salgado-Barreira, Á., Takkouche, B., López-López, R., Suárez-Cunqueiro, M. M., & Muinelo-Romay, L. (2020). Salivary biomarkers for cancer diagnosis: a meta-analysis. Annals of Medicine, 52(3–4), 131–144. https://doi.org/10.1080/07853890.2020.17304310785-3890https://hdl.handle.net/10347/43762Background: Saliva represents a promising non-invasive source of novel biomarkers for diagnosis and prognosis cancer. This meta-analysis evaluates the diagnostic value of salivary biomarkers for detection of malignant non-oral tumours to better define the value of saliva as an alternative liquid biopsy. Materials and methods: We performed a systematic review and meta-analysis. PubMed, Embase, LILACS and the Cochrane Library were searched to identify articles that examined the potential of salivary biomarkers for the diagnosis of malignant non-oral tumours. To assess the overall accuracy, we calculated the diagnostic odds ratio (DOR), area under hierarchical summary receiver operating characteristic (AUC) curve, sensitivity, specificity, positive likelihood ratio (PLR) and negative likelihood ratio (NLR) using a random- or fixed-effects model. Heterogeneity and publication bias were assessed. Statistical tests were two-sided. Results: One hundred fifty-five study units from 29 articles with 11,153 subjects were included. The pooled sensitivity, specificity, PLR, NLR, DOR and AUC were 0.76 (95% confidence intervals (CI), 0.74–0.77), 0.76 (95% CI, 0.75–0.77), 3.22 (95% CI, 2.92–3.55), 0.31 (95% CI, 0.28–0.34), 13.42 (95% CI, 12.28–15.96) and 0.85 (95% CI, 0.84–0.87), respectively. Conclusion: Salivary biomarkers may be potentially used for non-invasive diagnosis of malignant non-oral tumours.eng©2020 Informa UK Limited, trading as Taylor & Francis GroupAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/salivasalivary biomarkerssalivaomicscancerdiagnosisliquid biopsymeta-analysisjournal article10.1080/07853890.2020.17304311365-2060open access